TOPOTECAN News

TOPOTECAN currently has 8 news articles, with 35 predicted indications.

This page combines the AI-predicted indications for TOPOTECAN with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (35):
- hereditary site-specific ovarian cancer syndrome (99.0%)
- familial ovarian cancer (99.0%)
- cervical cancer (99.0%)
- maligant granulosa cell tumor of ovary (99.0%)
- malignant non-dysgerminomatous germ cell tumor of ovary (99.0%)
- malignant Sertoli-Leydig cell tumor of ovary (99.0%)
- borderline epithelial tumor of ovary (99.0%)
- ovarian clear cell adenocarcinoma (99.0%)
- malignant germ cell tumor of ovary (99.0%)
- ovarian mucinous adenocarcinoma (99.0%)
- yolk sac tumor (99.0%)
- ovarian adenocarcinoma (99.0%)
- immature ovarian teratoma (99.0%)
- ovarian endometrioid adenocarcinoma (99.0%)
- ovarian small cell carcinoma (99.0%)
- cervical carcinoma (99.0%)
- primary non-gestational choriocarcinoma of ovary (99.0%)
- cervical carcinosarcoma (99.0%)
- ovarian cancer (99.0%)📰 ovarian cancer
- theca steroid-producing cell malignant tumor of ovary, not further specified (99.0%)
- small cell lung carcinoma (99.0%)
- hereditary breast ovarian cancer syndrome (99.0%)
- malignant dysgerminomatous germ cell tumor of ovary (99.0%)
- malignant sex cord stromal tumor of ovary (99.0%)
- ovarian carcinosarcoma (99.0%)
- female breast carcinoma (99.9%)
- adult germ cell tumor (99.6%)
- testicular yolk sac tumor, solid pattern (99.5%)
- testicular yolk sac tumor, hepatoid pattern (99.5%)
- testicular yolk sac tumor, macrocystic pattern (99.5%)
- enteric pattern testicular yolk sac tumor (99.5%)
- polyvesicular vitelline pattern testicular yolk sac tumor (99.5%)
- testicular yolk sac tumor, papillary pattern (99.5%)
- testicular yolk sac tumor, endodermal sinus pattern (99.5%)
- reticular pattern testicular yolk sac tumor (99.5%)